Enrichment of circulating myeloma cells by immunomagnetic beads combined with flow cytometry for monitoring minimal residual disease and relapse in patients with multiple myeloma-Reference-Cited by-同舟云学术

Enrichment of circulating myeloma cells by immunomagnetic beads combined with flow cytometry for monitoring minimal residual disease and relapse in patients with multiple myeloma

Published:2019-11-20 Issue:12 Volume:98 Page:2769-2780
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Wang Ningning,Tesfaluul Nahom,Li Jia,Gao Xiaojuan,Liu Shuai,Yue Baohong^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-019-03833-5.pdf

Reference40 articles.

1. Siegel RL, Miller KD, Jemal A (2017) Cancer Statistics, 2017. CA Cancer J Clin 67(1):7–30. https://doi.org/10.3322/caac.21387

2. Röllig C, Knop S, Bornhäuser M (2015) Multiple myeloma. Lancet 385:2197–2208. https://doi.org/10.1016/s0140-6736(14)60493-1

3. Palumbo A, Rajkumar SV, San Miguel JF, Larocca A, Niesvizky R, Morgan G, Landgren O, Hajek R, Einsele H, Anderson KC, Dimopoulos MA, Richardson PG, Cavo M, Spencer A, Stewart AK, Shimizu K, Lonial S, Sonneveld P, Durie BG, Moreau P, Orlowski RZ (2014) International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 32 (6):587-600. doi:https://doi.org/10.1200/JCO.2013.48.7934

4. Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Zeldenrust SR, Dingli D, Russell SJ, Lust JA, Greipp PR, Kyle RA, Gertz MA (2008) Improved survival in multiple myeloma and the impact of novel therapies. Blood 111(5):2516–2520. https://doi.org/10.1182/blood-2007-10116129

5. Gonsalves WI, Rajkumar SV, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Dingli D, Go RS, Leung N, Kapoor P, Hayman SR, Lust JA, Russell SJ, Zeldenrust SR, Hwa YL, Kourelis TV, Kyle RA, Kumar SK (2016) Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy. Bone Marrow Transplant 51(8):1156–1158. https://doi.org/10.1038/bmt.2016.91

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant;HemaSphere;2024-04

2. Liquid biopsy by analysis of circulating myeloma cells and cell-free nucleic acids: a novel noninvasive approach of disease evaluation in multiple myeloma;Biomarker Research;2023-03-08

3. Liquid biopsy and blood-based minimal residual disease evaluation in multiple myeloma;Oncology Research;2023

4. Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells;Annals of Hematology;2022-02-01

5. Minimal Residual Disease in Multiple Myeloma: Potential for Blood-Based Methods to Monitor Disease;Clinical Lymphoma Myeloma and Leukemia;2022-01